Non-invasive Testing for Early oEesophageal Cancer and Dysplasia (NEED)
Non-invasive Testing for the Diagnosis of Early Oesophageal Cancer and Barrett's Dysplasia
Sponsor: Guts UK
This observational or N/A phase trial investigates Barrett Esophagus and Barretts Esophagus With Dysplasia and is currently ongoing. Guts UK leads this study, which shows 12 recorded versions since 2019 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Unknown
-
Aug 2025 — Sep 2025 [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2024 — Aug 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Aug 2023 — Jul 2024 [monthly]
Recruiting
Status: Unknown Status → Recruiting
▶ Show 7 earlier versions
-
May 2023 — Aug 2023 [monthly]
Unknown Status
Status: Not Yet Recruiting → Unknown Status
-
Mar 2022 — May 2023 [monthly]
Not Yet Recruiting
-
Jan 2021 — Mar 2022 [monthly]
Not Yet Recruiting
-
Feb 2020 — Jan 2021 [monthly]
Not Yet Recruiting
-
Dec 2019 — Feb 2020 [monthly]
Not Yet Recruiting
-
Sep 2019 — Dec 2019 [monthly]
Not Yet Recruiting
-
Jul 2019 — Sep 2019 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Guts UK
- Guy's and St Thomas' NHS Foundation Trust
- Imperial College London
- London North West Healthcare NHS Trust
- Northern Care Alliance NHS Foundation Trust
- Nottingham University Hospitals NHS Trust
- Oxford University Hospitals NHS Trust
- University College London Hospitals
- University Hospital Birmingham NHS Foundation Trust
For direct contact, visit the study record on ClinicalTrials.gov .